You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 13 March 2024

Sec. Inflammation Pharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1382529

Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

  • 1. Pharmacology and Toxicology Department, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt

  • 2. Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt

  • 3. Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia

  • 4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt

  • 5. Department of Family Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia

  • 6. Department of Child Health, College of Medicine, University of Bisha, Bisha, Saudi Arabia

  • 7. Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia

  • 8. Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

  • 9. Department of Pharmacology and Toxicology, Collage of Pharmacy, Taif University, Taif, Saudi Arabia

  • 10. Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

  • 11. Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia

  • 12. Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt

  • 13. Physiology Department, Benha Faculty of Medicine, Benha University, Banha, Egypt

  • 14. Physiology Department, Al-baha Faculty of Medicine, Al-baha University, AlBaha, Saudi Arabia

  • 15. Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, Egypt

  • 16. Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt

  • 17. Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia

  • 18. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

  • 19. Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Al Mansurah, Egypt

  • 20. Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, Saudi Arabia

  • 21. Central Laboratory, Theodor Bilharz Research Institute, Giza, Egypt

  • 22. Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha, Saudi Arabia

Article metrics

View details

1,4k

Views

557

Downloads

In the published article, there was an error in affiliations 11 and 12. Instead of:

11Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”

12Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”

it should be:

11Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”

12Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ulcerative colitis, β-hydroxybutyrate, NLRP3 inflammasome, apoptosis, pyroptosis

Citation

Abdelhady R, Saber S, Abdel-Reheim MA, Mohammad S. Alamri M, Alfaifi J, Adam MIE, Saleh LA, Farag AI, Elmorsy EA, El-Wakeel HS, Doghish AS, Shaker ME, Hazem SH, Ramadan HA, Hamad RS and Mohammed OA (2024) Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis. Front. Pharmacol. 15:1382529. doi: 10.3389/fphar.2024.1382529

Received

05 February 2024

Accepted

07 February 2024

Published

13 March 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Sameh Saber, ; Mustafa Ahmed Abdel-Reheim, ; Osama A. Mohammed,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics